Blog

Updated on Sep 8, 2025 | Published on Oct 12, 2021 Share

Akadeum Life Sciences closes an oversubscribed round and plans to expand commercialization of proprietary biological separation platform.  Dan Kidle, Managing Partner at Arboretum Ventures, joins Akadeum board of directors. October 12, 2021, Ann Arbor, MI – Akadeum Life Sciences, Inc., today announced the closing of an oversubscribed $17.5 million Series B financing led by Arboretum Ventures. Investors in the round also included Beringea, Agilent Technologies (NYSE:A), Lifespan Ventures, BlueStone Venture …

Updated on Sep 8, 2025 | Published on Jan 9, 2024 Share

Partnership uses Akadeum’s revolutionary microbubble technology for viral processing. ANN ARBOR, Michigan, Jan. 5, 2024 – Akadeum Life Sciences, Inc., announced today an innovative solution for the detection of viral DNA/RNA in wastewater, developed from a collaboration with Agilent Technologies, Inc. which started in October 2019. Wastewater surveillance monitoring has become an important method for mass screening of communities, offering an early warning system for emerging infectious diseases like SARS-CoV-2. …

Updated on Sep 8, 2025 | Published on Aug 15, 2017 Share

Akadeum’s groundbreaking microbubble technology—which allows for fast, easy removal of target cells from biological samples—was recognized as the best new technology at CYTO Innovation 2017. Each year, the top minds in cytometry—which refers to the methodology used to extract quantitative information from individual cells—join together at ISAC’s CYTO Innovation to present the industry’s new technologies in the technology showcase. This year, we rose to the top as the clear winner. …

Updated on Sep 8, 2025 | Published on Sep 21, 2022 Share

Akadeum’s microbubble technology allows scientists to effortlessly process up to twice as many leukopaks in as little as one-third the time of traditional methods, increasing throughput and optimizing processes ANN ARBOR, Mich., Sept. 21, 2022 — Akadeum Life Sciences, Inc., a global leader in buoyancy-based cell separation technology, announces a new early access program launch of an industry-first: the Microbubble Leukopak Human T Cell Isolation Kit. This new research use-only kit …

Updated on Sep 8, 2025 | Published on Jan 8, 2024 Share

With products that gently isolate and activate cells, Akadeum’s founder and CEO will discuss the impact the company is having on the cell and gene therapy space. ANN ARBOR, MI, Jan. 8, 2024 – Akadeum Life Sciences—the global leader in buoyancy-based cell separation technology—has been selected to present on its revolutionary microbubble platform at this year’s Biotech Showcase, which is being held from January 8-10 in San Francisco. Brandon McNaughton, …

Updated on Sep 8, 2025 | Published on Aug 25, 2022 Share

This new buoyant separation method creates a more effective way for researchers to use valuable samples with a higher retention rate of viable cells than current magnetic techniques Ann Arbor, MI – August 4, 2022 – Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics, and cell and molecular research for human health and life sciences—announces today the launch of their Dead Cell Removal …

Updated on Sep 8, 2025 | Published on May 12, 2021 Share

Coming in June: Join Akadeum at CYTO 2021! Akadeum has had two abstracts accepted for CYTO Virtual Interactive 2021, which is planned for June 7-10 this year. This year’s virtual conference promises to be a unique experience, and even though we may not be able to grab a cup of coffee together and chat in person, we’re looking forward to connecting virtually to share these two posters with flow core …

Updated on Sep 8, 2025 | Published on Oct 7, 2024 Share

Following a highly successful beta and demo period, Akadeum is moving full steam ahead toward the formal launch of the Alerion™ Microbubble Cell Separation System. PHOENIX, AZ, Oct. 1, 2024 — Akadeum Life Sciences is excited to announce its participation in the upcoming Cell and Gene Meeting on the Mesa, a globally recognized conference held at the iconic Arizona Biltmore. This premier event brings together senior executives and key decision-makers from the cell …

Updated on Sep 8, 2025 | Published on Jan 17, 2024 Share

The Human T Cell Selection, Activation, and Expansion and Human T Cell Depletion kits use Akadeum’s BACS™ microbubbles to streamline cell therapy workflows. ANN ARBOR, MI, Jan 16, 2024 – Today, Akadeum Life Sciences, the market leader in buoyancy-based cell separation is announcing the release of a Human T Cell Selection, Activation, and Expansion Kit (GMP Grade), and a Human T Cell Depletion Kit (GMP Grade) at the Advanced Therapies …

Updated on Sep 8, 2025 | Published on May 6, 2022 Share

Akadeum to showcase high-purity, high-yield isolation of Human B cells without the need for a column or magnet ANN ARBOR, Mich., May 06, 2022 — Akadeum Life Sciences, Inc.—a global leader in buoyancy-based technology in cell therapy manufacturing, clinical diagnostics and cell and molecular research for human health and life sciences—today announced the expansion of its cell separation product portfolio with a new human B cell isolation product and updated …